BioNTech SE (BNTX) Long-Term Debt Repayments (2019 - 2025)
BioNTech SE (BNTX) posted Long-Term Debt Repayments of -$10.0 million for Q4 2025, down 613.59% on a QoQ basis from -$1.4 million in Q3 2025.
BioNTech SE (BNTX) has 7 years of Long-Term Debt Repayments data on file, last reported at -$10.0 million in Q4 2025.
- In Q4 2025, Long-Term Debt Repayments changed N/A year-over-year to -$10.0 million; the TTM figure through Dec 2025 stood at -$20.3 million (up 99.29% YoY), while the FY2025 annual figure was -$20.3 million, down 727.44% from the prior year.
- Long-Term Debt Repayments declined to -$10.0 million in Q4 2025, from -$1.4 million in the prior quarter.
- Across five years, Long-Term Debt Repayments topped out at -$0.84 in Q1 2021 and bottomed at -$2.9 billion in Q1 2024.
- A 5-year average of -$339.4 million and a median of -$3.3 million in 2024 frame the typical range for Long-Term Debt Repayments.
- Annual changes were most pronounced in 2022 — Long-Term Debt Repayments slumped 2498912357.2% — and 2025, when it jumped 99.83%.
- Year by year, Long-Term Debt Repayments stood at -$58.0 in 2021, then tumbled by 32682274.62% to -$19.0 million in 2022, then jumped by 99.43% to -$108859.0 in 2023, then sank by 2175.27% to -$2.5 million in 2024, then sank by 304.18% to -$10.0 million in 2025.
- The last three Long-Term Debt Repayments figures came in at -$10.0 million (Q4 2025), -$1.4 million (Q3 2025), and -$4.2 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Repayments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | BioNTech SE | 27.66 Bn | 7.53 Bn | 668.28 Mn | -10.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -10.01 Mn |
| Dec 31, 2025 | -10.01 Mn |
| Sep 30, 2025 | -1.40 Mn |
| Sep 30, 2025 | -1.40 Mn |
| Jun 30, 2025 | -4.19 Mn |
| Jun 30, 2025 | -4.19 Mn |
| Mar 31, 2025 | -4.73 Mn |
| Mar 31, 2025 | -4.73 Mn |
| Jun 30, 2024 | -2.48 Mn |
| Jun 30, 2024 | -2.48 Mn |
| Mar 31, 2024 | -2.86 Bn |
| Mar 31, 2024 | -2.86 Bn |
| Sep 30, 2023 | -108,859.05 |
| Sep 30, 2023 | -108,859.05 |
| Mar 31, 2023 | -1.83 Bn |
| Mar 31, 2023 | -1.83 Bn |
| Sep 30, 2022 | -18.96 Mn |
| Sep 30, 2022 | -18.96 Mn |
| Mar 31, 2022 | -21.10 Mn |
| Mar 31, 2022 | -21.10 Mn |
| Dec 31, 2021 | -58.00 |
| Dec 31, 2021 | -58.00 |
| Sep 30, 2021 | -2.24 Mn |
| Sep 30, 2021 | -2.24 Mn |
| Jun 30, 2021 | -842,990.01 |
| Jun 30, 2021 | -842,990.01 |
| Mar 31, 2021 | -0.84 |
| Mar 31, 2021 | -0.84 |
| Dec 31, 2020 | -0.83 |
| Dec 31, 2020 | -0.83 |
| Mar 31, 2020 | 74.63 Mn |
| Mar 31, 2020 | 74.63 Mn |
| Mar 31, 2019 | 72.09 Mn |
| Mar 31, 2019 | 72.09 Mn |